Showing results (201-210 of 286) with videos related to
Sort By:
Pageof 29
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 casesJerzy Lasota, Christopher L Corless, Michael C Heinrich, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2021
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcomaAlyssa J Penning, Alyaa Al-Ibraheemi, Michael Michal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaEdgar Ben-Josef, Katherine A Guthrie, Anthony B El-Khoueiry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumorMichael C Heinrich, Robert G Maki, Christopher L Corless, et al.Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205Philip A Philip, Jacqueline Benedetti, Christopher L Corless, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trialChristopher L Corless, Karla V Ballman, Cristina R Antonescu, et al.Journal of Clinical and Translational Science|February 22, 2024
Novel recruitment approaches and operational results for a statewide population Cohort for cancer research: The Healthy Oregon ProjectZhenzhen Zhang, Autumn Shafer, Katie Johnson-Camacho, et al.Genome Biology|March 26, 2009
Integrated analysis of breast cancer cell lines reveals unique signaling pathwaysLaura M Heiser, Nicholas J Wang, Carolyn L Talcott, et al.Pageof 29